Manufacturer record
Askon Health Care: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Askon Health Care (Madhya Pradesh) were declared Not of Standard Quality between November 2022 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Askon Health Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Tablets IP 400 mg | IBK-2503Mfg 2025-06 · Exp 2028-05 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab | Jun 2026 |
| Riboflavin Tablets IP 5 mg | RB-2433Mfg 2024-11 · Exp 2027-10 | The sample does not conform to I.P.w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Mar 2026 |
| Riboflavin Tablets IP 5 MG | RB-2433Mfg 2024-11 · Exp 2027-10 | The sample does not conform to I.P. w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Paracetamol 500 mg. Tablets | PAR-31Mfg 2023-08 · Exp 2026-07 | The sample Does not Complies conforms to I.P. with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Primaquine Phosphate Tablets IP | PQH-08Mfg 2021-11 · Exp 2024-10 | AssayAssay | RDTL GuwahatiState lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.